Clinical Trial

CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer

Name: CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer — clinical trial record (NCT07278986)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CYTALUX ISS

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

The research study is being done to assess the safety and ability of an investigational drug called CYTALUX (pafolacianine) and a special camera system for the detection of cancer in patients undergoing surgical resection for endometrial cancer.

Trial Details

NCT Number	NCT07278986
Lead Sponsor	Abramson Cancer Center at Penn Medicine
Conditions	Endometrial Cancer, Near Infrared Fluorescence Imaging, CYTALUX (Pafolacianine) Injection, Planned Diagnostic Laparoscopies
Enrollment	10 participants
Start Date	2025-10-18
Primary Completion	2027-10 (estimated)
Study Completion	2029-02 (estimated)
Updated on ClinicalTrials.gov	2025-12-12